相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New HCV therapies on the horizon
J. Vermehren et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
Stephanie T. Shi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy
Ira M. Jacobson
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Hepatitis C Virus Drug Resistance and Immune-Driven Adaptations: Relevance to New Antiviral Therapy
Silvana Gaudieri et al.
HEPATOLOGY (2009)
Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients
Simone Susser et al.
HEPATOLOGY (2009)
ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1
I. Jacobson et al.
JOURNAL OF HEPATOLOGY (2009)
HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON (TM) (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C
P. Kwo et al.
JOURNAL OF HEPATOLOGY (2009)
GENOTYPIC CHARACTERISATION OF HCV NS5B FOLLOWING 8-DAY MONOTHERAPY WITH THE POLYMERASE INHIBITOR PF-00868554 IN HCV-INFECTED SUBJECTS
P. Troke et al.
JOURNAL OF HEPATOLOGY (2009)
Evaluation of VCH-759 monotherapy in hepatitis C infection
Curtis Cooper et al.
JOURNAL OF HEPATOLOGY (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naive Patients
Thomas Kuntzen et al.
HEPATOLOGY (2008)
In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Stephanie T. Shi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
Christoph Sarrazin et al.
GASTROENTEROLOGY (2007)
Global challenges in liver disease
Roger Williams
HEPATOLOGY (2006)
High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C
K Lindahl et al.
HEPATOLOGY (2005)
The Los Alamos hepatitis C sequence database
C Kuiken et al.
BIOINFORMATICS (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme
RA Love et al.
JOURNAL OF VIROLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
分享论文
